-deficient mice. Immunity.

;

:

–

References

Haziot A, Chen S, Ferrero E, Low MG, Silber R, Goyert SM. The mono- cyte differentiation antigen, CD

, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol.

;

:

–

Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD

, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science.

;

:

–

Tobias PS, Ulevitch RJ. Lipopolysaccharide binding protein and CD

in LPS dependent macrophage activation. Immunobiology.

;

:

–

Bazil V, Baudys M, Hilgert I, Stefanová I, Low MG, Zbrozek J, Horejsí V. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD

Mol Immunol.

;

:

–

Bazil V, Strominger JL. Shedding as a mechanism of down-modulation of CD

on stimulated human monocytes. J Immunol.

;

:

–

Durieux JJ, Vita N, Popescu O, Guette F, Calzada-Wack J, Munker R, Schmidt RE, Lupker J, Ferrara P, Ziegler-Heitbrock HW. The two soluble forms of the lipopolysaccharide receptor, CD

: characterization and release by normal human monocytes. Eur J Immunol.

;

:

–

Bufler P, Stiegler G, Schuchmann M, Hess S, Krüger C, Stelter F, Eckerskorn C, Schütt C, Engelmann H. Soluble lipopolysaccharide receptor (CD

) is released via two different mechanisms from human monocytes and CD

transfectants. Eur J Immunol.

;

:

–

Su GL, Dorko K, Strom SC, Nüssler AK, Wang SC. CD

expression and production by human hepatocytes. J Hepatol.

;

:

–

Pan Z, Zhou L, Hetherington CJ, Zhang DE. Hepatocytes contribute to soluble CD

production, and CD

expression is differentially regulated in hepatocytes and monocytes. J Biol Chem.

;

:

–

Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C. CD

is an acute- phase protein. J Immunol.

;

:

–

Pugin J, Schürer-Maly CC, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD

Proc Natl Acad Sci USA.

;

:

–

Juan TS, Kelley MJ, Johnson DA, Busse LA, Hailman E, Wright SD, Lichenstein HS. Soluble CD

truncated at amino acid

binds lipo- polysaccharide (LPS) and enables cellular response to LPS. J Biol Chem.

;

:

–

Kitchens RL, Thompson PA. Modulatory effects of

D

and LBP on LPS-host cell interactions. J Endotoxin Res.

;

:

–

Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism* in the

’ flanking region of the CD

gene is associ- ated with circulating soluble CD

levels and with total serum immuno- globulin E. Am J Respir Cell Mol Biol.

;

:

–

L

an TD, Bloom JW, Bailey TJ, Karp CL, Halonen M, Martinez FD, Vercelli D. A common single nucleotide polymorphism in the CD

promoter decreases the affinity of Sp protein binding and enhances tran- scriptional activity. J Immunol.

;

:

–

Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A. The Cardiovascular Health Study: design and rationale. Ann Epidemiol.

;

:

–

O’Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA. Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke.

;

:

–

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet.

;

:

–

Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ. Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered.

;

:

–

Design of the Women’s Health Initiative clinical trial and observational study. The Women’s Health Initiative Study Group. Control Clin Trials.

;

:

–